Renovaro Historical Income Statement
| RENB Stock | 0.61 0.09 17.31% |
Historical analysis of Renovaro Biosciences income statement accounts such as Total Other Income Expense Net of 1 M, Depreciation And Amortization of 107.2 K, Total Revenue of 0.0 or Cost Of Revenue of 166 K can show how well Renovaro Biosciences performed in making a profits. Evaluating Renovaro Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Renovaro Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Renovaro Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Renovaro Biosciences is a good buy for the upcoming year.
Renovaro |
About Renovaro Income Statement Analysis
Renovaro Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Renovaro Biosciences shareholders. The income statement also shows Renovaro investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Renovaro Biosciences Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Renovaro Biosciences. It is also known as Renovaro Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Cost Of Revenue
Cost of Revenue is found on Renovaro Biosciences income statement and represents the costs associated with goods and services Renovaro Biosciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Renovaro Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Renovaro Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renovaro Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Renovaro Stock refer to our How to Trade Renovaro Stock guide.At present, Renovaro Biosciences' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 25.4 M, whereas Operating Income is projected to grow to (77.6 M).
Renovaro Biosciences income statement Correlations
Click cells to compare fundamentals
Renovaro Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Renovaro Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 104.3K | 379.6K | 372.8K | 707.0K | 1.0M | 1.1M | |
| Selling General Administrative | 7.1M | 7.6M | 14.3M | 15.3M | 24.2M | 25.4M | |
| Other Operating Expenses | 11.9M | 23.4M | 22.8M | 19.6M | 81.6M | 85.7M | |
| Operating Income | (11.9M) | (23.4M) | (116.1M) | (38.6M) | (81.6M) | (77.6M) | |
| Ebit | (11.9M) | (23.4M) | (22.8M) | (19.6M) | (79.6M) | (75.7M) | |
| Total Operating Expenses | 11.9M | 23.4M | 22.8M | 19.6M | 81.6M | 85.7M | |
| Income Before Tax | (11.4M) | (26.8M) | (113.4M) | (39.7M) | (80.7M) | (76.6M) | |
| Net Income | (11.4M) | (26.7M) | (113.4M) | (39.7M) | (80.7M) | (76.6M) | |
| Total Other Income Expense Net | 561.4K | (3.4M) | 2.6M | (1.1M) | 989.1K | 1.0M | |
| Depreciation And Amortization | 366.3K | 123.5K | 123.6K | 113.5K | 121.9K | 107.2K | |
| Gross Profit | (366.3K) | (391.4K) | (123.6K) | (113.5K) | (121.9K) | (128.0K) | |
| Ebitda | (11.5M) | (23.3M) | (22.7M) | (19.5M) | (79.5M) | (75.5M) | |
| Cost Of Revenue | 366.3K | 391.4K | 123.6K | 113.5K | 121.9K | 166.0K | |
| Interest Income | 50.3K | 13.2K | 122.0K | 115.1K | 103.6K | 72.3K | |
| Net Income From Continuing Ops | (11.4M) | (26.7M) | (113.4M) | (39.7M) | (35.7M) | (37.5M) | |
| Research Development | 4.7M | 15.7M | 8.4M | 4.2M | 2.7M | 4.5M | |
| Net Income Applicable To Common Shares | (11.4M) | (26.7M) | (113.4M) | (39.7M) | (35.7M) | (37.5M) | |
| Income Tax Expense | 1.0 | 104.3K | (125.3K) | 34.0 | 707.0K | 1.05 | |
| Net Interest Income | (54.0K) | (366.4K) | (250.8K) | (707.0K) | (636.3K) | (604.5K) | |
| Reconciled Depreciation | 108.6K | 391.4K | 123.6K | 113.5K | 102.1K | 97.0K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Renovaro Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Renovaro Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Renovaro Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Renovaro Biosciences Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renovaro Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Renovaro Stock refer to our How to Trade Renovaro Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Renovaro Biosciences. If investors know Renovaro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Renovaro Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.98) | Return On Assets (0.15) | Return On Equity (0.90) |
The market value of Renovaro Biosciences is measured differently than its book value, which is the value of Renovaro that is recorded on the company's balance sheet. Investors also form their own opinion of Renovaro Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Renovaro Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Renovaro Biosciences' market value can be influenced by many factors that don't directly affect Renovaro Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Renovaro Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Renovaro Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Renovaro Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.